Evidence behind this recommendation.
Selected studies from our library that inform the recommendations on this page. Evidence grade shown when available.
Revealing the clinical effect and biological mechanism of acupuncture in COPD: A review
“Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality worldwide, characterized by irreversible airflow limitation and chronic airway inflammation. This systematic review analyzed 45 studies...”
Anti-inflammatory effects of acupuncture in the treatment of chronic obstructive pulmonary disease
“This narrative review offers a comprehensive analysis of the anti-inflammatory mechanisms of acupuncture in the treatment of chronic obstructive pulmonary disease (COPD), drawing on 27 studies with animal models. COPD is characterized by inflammation...”
What COPD Is
Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable respiratory disease characterized by persistent respiratory symptoms and chronic airflow limitation caused by significant exposure to noxious gases or particles — primarily tobacco smoke (80 to 90% of cases in Brazil). The diagnosis is confirmed by spirometry: post-bronchodilator FEV1/FVC <0.70 (GOLD criterion).
COPD is a systemic disease with manifestations beyond the lung: peripheral muscle dysfunction, malnutrition, cachexia, osteoporosis, cardiovascular disease, and depression. The main feature that limits quality of life is progressive dyspnea — especially with exertion — leading to a vicious cycle of inactivity → deconditioning → worsening dyspnea → still more inactivity. Worldwide it is the third leading cause of death; in Brazil, it affects about 16 million adults.
The Vicious Cycle of COPD
Conventional Treatments
COPD treatment is predominantly symptomatic and preventive. Smoking cessation is the only intervention proven to alter the FEV1 decline curve and disease progression.
PILLARS OF COPD TREATMENT
| INTERVENTION | BENEFIT | LEVEL OF EVIDENCE |
|---|---|---|
| Smoking cessation | The only intervention that alters disease progression | A — absolute priority |
| LAMA (tiotropium, umeclidinium) | Reduces dyspnea, hyperinflation, and exacerbations | A — first line in GOLD 2–4 |
| LABA (indacaterol, formoterol) | Long-acting bronchodilation | A — in combination with LAMA |
| Pulmonary rehabilitation | Improves dyspnea, 6MWT, and quality of life | A — underused in Brazil |
| Home oxygen therapy | Reduces mortality in COPD with hypoxemia | A — resting SpO2 <88% |
| Vaccines (influenza, pneumococcus) | Reduction of infectious exacerbations | A — mandatory |
How Acupuncture Works in COPD
In COPD, acupuncture acts on three fronts: reduction of dyspnea by modulation of the respiratory reflex, improvement of respiratory muscle function, and reduction of dynamic hyperinflation through relaxation of the flattened diaphragm.
Mechanism of Action in COPD
BL-13 (Feishu) + CV-17 — Modulation of the Respiratory Reflex
BL-13 (T3) activates segmental afferents → reduces sympathetic hyperactivation of the pontine respiratory center; CV-17 modulates central perception of dyspnea via vagal TRPV1 fibers.
ST-36 + ST-40 — Respiratory Muscle Strength
Improvement in strength and endurance of accessory respiratory muscles (scalenes, sternocleidomastoid); ST-40 (Fenglong) — the "phlegm-transformation" point — reduces mucus secretion and improves expectoration.
KI-3 (Taixi) — Renal Foundation of Respiration
In Chinese medicine, "the Kidney governs the grasping of respiratory Qi"; in modern terms, KI-3 improves the response to exercise by regulating tissue O2 saturation and peripheral muscle mitochondrial efficiency.
Reduction of Dynamic Hyperinflation
Relaxation of the flattened diaphragm and accessory intercostal muscles → improved tidal volume → reduction of the functional residual capacity that is pathologically elevated in severe COPD.
TRPV1 (Capsaicin Receptor) Modulation
TRPV1 receptors in the airways mediate the perception of dyspnea and cough. Acupuncture reduces sensitization of these receptors → reduction of the subjective sensation of breathlessness independent of objective lung function.
Scientific Evidence
BMJ Open Respir Res 2020 — RCT (n=147)
J Altern Complement Med 2019 — Meta-analysis (12 RCTs, n=847)
Modern Approach: Medical Acupuncture in COPD
CLINICAL PROTOCOL IN COPD
| PARAMETER | SPECIFICATION | RATIONALE |
|---|---|---|
| Main points | BL-13 + ST-36 + CV-17 | Pulmonary + systemic + central respiratory |
| Auxiliary points | KI-3 + ST-40 + LU-7 | Renal foundation + phlegm + lung meridian |
| Electroacupuncture | 2 Hz on BL-13+ST-36 | Respiratory muscle strength |
| Frequency | 2 sessions/week for 12 weeks | 6MWT every 4 weeks for monitoring |
| Goal in mild-moderate COPD | Increase 6MWT and reduce MRC | Enable pulmonary rehabilitation |
| Goal in severe COPD | Reduce dyspnea and improve CAT | Quality of life as primary outcome |
When to See a Medical Acupuncturist
Priority Indications
- COPD GOLD 2–3 with significant functional limitation
- Dyspnea MRC ≥3 — preventing pulmonary rehabilitation
- Very low quality of life (CAT >20)
- Concurrent smoking cessation
- Frequent exacerbations with anxiety component
Requires Prior Evaluation
- Recent spirometry for GOLD staging
- Resting and exertional SpO2 before starting
- COPD GOLD 4 with hypoxemia: home O2 takes priority
- Acute exacerbation: antibiotic + systemic corticosteroid first
Frequently Asked Questions
Frequently Asked Questions
No. COPD causes irreversible alveolar destruction (emphysema) and airway remodeling that is not reversed by any current treatment. Acupuncture improves symptoms, exercise capacity, and quality of life — but does not restore the destroyed lung tissue. Spirometry rarely changes; the outcomes are functional.
No. LAMA/LABA bronchodilators are the pharmacological foundation of GOLD 2–4 treatment and should not be replaced. Acupuncture acts as a complementary therapy — it can contribute to the control of dyspnea and functional capacity, always coordinated with the pulmonologist who manages the bronchodilator treatment.
The BMJ Open study (2020) observed significant improvement in 6MWT and CAT after 12 weeks (24 sessions). Earlier improvement in dyspnea is typically reported starting from the 4th to 6th session. Monitoring with 6MWT every 4 weeks allows objective assessment of response.
It is not indicated as treatment for acute exacerbations — which require bronchodilators, systemic corticosteroids, and antibiotics when bacterial. After resolution of the exacerbation, the acupuncture cycle can be restarted for rehabilitation and prevention of new exacerbations.
Yes. Home oxygen and acupuncture are compatible. In GOLD 4 patients with hypoxemia, acupuncture focuses on quality of life and dyspnea reduction, not significant functional improvement (which is limited by disease severity). The pulmonologist should coordinate all interventions.